Emerging role for sphingolipids in the genetics of amyotrophic lateral sclerosis
J Neurol Neurosurg Psychiatry
.
2024 Jan 11;95(2):101-102.
doi: 10.1136/jnnp-2023-332719.
Authors
Matthew C Kiernan
1
2
,
Michelle Anne Farrar
3
4
Affiliations
1
Bushell Chair of Neurology, Brain and Mind Centre, University of Sydney, Sydney, New South Wales, Australia matthew.kiernan@sydney.edu.au.
2
Neurology, Royal Prince Alfred Hospital, Camperdown, New South Wales, Australia.
3
Neurology, Sydney Children's Hospital Randwick, Randwick, New South Wales, Australia.
4
School of Women's and Children's Health, UNSW Medicine, UNSW, Sydney, New South Wales, Australia.
PMID:
38041659
DOI:
10.1136/jnnp-2023-332719
No abstract available
Keywords:
ALS; MOTOR NEURON DISEASE; NEUROGENETICS; NEUROMUSCULAR.
Publication types
Editorial
MeSH terms
Amyotrophic Lateral Sclerosis* / genetics
Humans
Motor Neuron Disease*
Sphingolipids
Substances
Sphingolipids